Want to join the conversation?
$DGX's Diagnostic Information Services (DIS) revenue, which accounted for over 90% of its consolidated net revenues, was flat for 3Q15 compared to the prior year period. DIS 3Q15 volume, measured by the number of requisitions, fell 0.2% while revenue per requisition rose 0.2% YoverY.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.